product summary
Loading...
company name :
Bon Opus Biosciences
product type :
protein
product name :
Recombinant Human Oxidized Low-Density Lipoprotein Receptor 1/OLR1 (C-6His)
catalog :
C524
quantity :
10 ug;50 ug;500 ug;1 mg
more info or order :
product information
Cat# :
C524
Type :
Recombinant Protein
name :
Recombinant Human Oxidized Low-Density Lipoprotein Receptor 1/OLR1 (C-6His)
collection :
Immunity;Recombinant Proteins
sku :
C524-10ug
productOptionDescription1 :
10 ug;50 ug;500 ug;1 mg
Accession Number :
P78380
Background :
Oxidized Low-Density Lipoprotein Receptor 1 (Ox-LDL Receptor 1) is a secreted, single-pass type II membrane protein which belongs to the C-type lectin superfamily. Ox-LDL Receptor 1 is expressed at high levels in endothelial cells and vascular-rich organs such as placenta, lung, liver, brain, aortic intima, bone marrow, spinal cord and substantia nigra. The expression of Ox-LDL Receptor 1 is induced by inflammatory cytokines such as TNF, IFNG and IL6 by pathological conditions, such as hyperlipidemia, hypertension and diabetes mellitus. Ox-LDL Receptor 1 mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (OxLDL) by vascular endothelial cells. Ox-LDL Receptor 1 association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. Ox-LDL Receptor 1 also binds to oxLDL, which acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. It also participates in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation.
Expression :
Human Cells
Packaging :
Ambient
Formulation :
Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2.
ALTnames :
Oxidized Low-Density Lipoprotein Receptor 1, Ox-LDL Receptor 1, C-Type Lectin Domain Family 8 Member A, Lectin-Like Oxidized LDL Receptor 1, LOX-1, Lectin-Like oxLDL Receptor 1, hLOX-1, Lectin-Type Oxidized LDL Receptor 1, OLR1, CLEC8A, LOX1
more info or order :
company information

Bon Opus Biosciences
150 Essex St. Suite 301
Millburn, NJ 07041
Millburn, NJ 07041
sales@bonopusbio.com
http://www.bonopusbio.com1-800-943-6396
headquarters: USA
Bon Opus Biosciences is a biotech company providing essential reagents to life science community. Bon Opus is derived from the Latin "Bonum Opus," which translates to good work. We are a team of like-minded and determined individuals, all sharing a vision for success. The catalog product includes primary antibody and recombinant proteins. The scope of services offered ranges from gene synthesis to recombinant protein expression, peptide synthesis, recombinant antibody production.
Every customer is our VIP:
Flat rate charge for gene synthesis, recombinant protein production
Our reagents, your discovery!
Every customer is our VIP:
Flat rate charge for gene synthesis, recombinant protein production
- Guaranteed quality
- Flexible and care
- Fast turnaround time
- Affordable cost
Our reagents, your discovery!
browse more products
- Recombinant Human PACSIN1/Syndapin-1 (C-6His) | C834
- Recombinant Human PAF-AH/PLA2G7 (C-6His) | C624
- Recombinant Human Pancreatic Lipase-Related Protein 1/PLRP1 (C-6His) | C681
- Recombinant Human Pancreatic Lipase-Related Protein 2/PLRP2 (C-6His) | CA52
- Recombinant Human Pancreatic Polypeptide/PPY (C-6His) | CI10
questions and comments